Compression Therapy - APAC Analysis and Market Forecasts
Summary
Compression therapy products, especially static compression devices, have become the standard in the treatment of venous conditions, such as deep vein thrombosis (DVT), varicose veins, and venous leg ulcers, and lymphatic disorders, such as primary and secondary lymphedema. While elastic stockings and compression bandaging have played important roles in providing effective therapies, newer modes of static compression such as custom garments and adjustable products have been introduced to ease patient burden and improve treatment compliance. Pneumatic compression devices have similarly advanced, despite their lower adoption rates. Segmented pumps with tunable pressure characteristics have joined the ranks of simpler devices with single outputs for single inflatable chambers in the treatment of venous and lymphatic conditions. Although pneumatic compression has not quite been an arena of rapid innovation, some manufacturers have developed advanced pump systems that deliver complex pressure profiles to the affected areas of the patients’ bodies. This report focuses on both static and pneumatic compression market categories. The APAC compression therapy market has been estimated in this report, which covers Japan, China and India up to 2021. The report provides an investigation of unmet needs, future adoption trends and compound annual growth rates (CAGR) for each geography and market segment. In addition, this report presents the current market drivers and barriers which will influence the future market growth of compression therapy in the APAC region.
*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.
Highlights
Key Questions Answered
- What is the current and future market outlook for compression therapy products in the APAC region? What trends are affecting the compression therapy market?
- Which are the key, high growth markets? What compression therapy segments are growing the fastest?
- What are the unmet needs? What is the scope for more innovation and what are the end-users looking for in their products?
- What are some of the newer innovations that may fulfill these unmet needs? What are the physician perceptions and market outlooks?
- Sigvaris, BSN Medical, Medi, and Medtronic currently dominate the global compression therapy market. What are their market shares in the APAC economies and which companies constitute the remainder of the market?
Reasons to buy
- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading physicians and other stakeholders from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
Summary
Compression therapy products, especially static compression devices, have become the standard in the treatment of venous conditions, such as deep vein thrombosis (DVT), varicose veins, and venous leg ulcers, and lymphatic disorders, such as primary and secondary lymphedema. While elastic stockings and compression bandaging have played important roles in providing effective therapies, newer modes of static compression such as custom garments and adjustable products have been introduced to ease patient burden and improve treatment compliance. Pneumatic compression devices have similarly advanced, despite their lower adoption rates. Segmented pumps with tunable pressure characteristics have joined the ranks of simpler devices with single outputs for single inflatable chambers in the treatment of venous and lymphatic conditions. Although pneumatic compression has not quite been an arena of rapid innovation, some manufacturers have developed advanced pump systems that deliver complex pressure profiles to the affected areas of the patients’ bodies. This report focuses on both static and pneumatic compression market categories. The APAC compression therapy market has been estimated in this report, which covers Japan, China and India up to 2021. The report provides an investigation of unmet needs, future adoption trends and compound annual growth rates (CAGR) for each geography and market segment. In addition, this report presents the current market drivers and barriers which will influence the future market growth of compression therapy in the APAC region.
*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.
Highlights
Key Questions Answered
- What is the current and future market outlook for compression therapy products in the APAC region? What trends are affecting the compression therapy market?
- Which are the key, high growth markets? What compression therapy segments are growing the fastest?
- What are the unmet needs? What is the scope for more innovation and what are the end-users looking for in their products?
- What are some of the newer innovations that may fulfill these unmet needs? What are the physician perceptions and market outlooks?
- Sigvaris, BSN Medical, Medi, and Medtronic currently dominate the global compression therapy market. What are their market shares in the APAC economies and which companies constitute the remainder of the market?
Reasons to buy
- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading physicians and other stakeholders from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Industry Overview
3.1 Overview
3.2 Anatomy & Physiology
3.2.1 Chronic Venous Disease
3.2.2 Varicose Veins
3.2.3 Venous Leg Ulcers
3.2.4 Venous Thromboembolism and Deep Vein Thrombosis
3.2.5 Lymphedema
3.3 Clinical Outcomes
3.3.1 Venous Conditions
3.3.2 Lymphedema
3.4 Applications of Technology
3.4.1 Static Compression
3.4.2 Pneumatic Compression Devices
3.5 Advantages and Disadvantages of Technology
3.6 Market Access
3.7 Influence of Clinical Trials
3.8 Regulatory Process
3.8.1 Overview
3.8.2 Japan
3.8.3 China
3.8.4 India
3.9 Reimbursement
3.9.1 Overview
3.9.2 Japan
3.9.3 China
3.9.4 India
3.10 Regulatory Issue & Key Deals
3.10.1 Regulatory Issues & Recalls
3.10.2 Mergers, Acquisitions, and Key Partnerships
3.11 Economic Impact
3.11.1 Indirect Costs
3.11.2 Direct Costs
4 Unmet Needs
4.1 Overview
4.2 Improving Patient Education
4.3 Implementing Consistent Bandaging
4.4 Expanding Caregiver Education
4.5 Enhancing Patient Comfort
4.6 Supporting Patient Mobility
5 Market Opportunity Analysis
5.1 Overview
5.2 Engineering Adjustable Garments for Greater Flexibility
5.3 Developing Multilayer Stockings for Easier Application
5.4 Improving Compression Garments by Adding Sensors
5.5 Innovating Automated Bandaging for Consistent Treatment
6 Market Drivers and Barriers
6.1 Drivers
6.1.1 Aging Populations
6.1.2 Cancer-Related Lymphedema
6.1.3 Rising Rates of Obesity
6.1.4 Lymphatic Filariasis in Underdeveloped Regions
6.1.5 The Need for Cost Savings
6.2 Barriers
6.2.1 Insufficient Reimbursement
6.2.2 Patient Compliance
6.2.3 Cost of Care
6.2.4 Medical Device Excise Tax
6.2.5 Availability of Venture Capital
6.3 Substitutes
6.3.1 Procedures to Prevent Thromboembolism
6.3.2 Invasive and Non-invasive Interventions for Varicose Veins
6.3.3 Surgical Interventions for Lymphedema
6.3.4 Pharmacological Options for DVT Management
7 Competitive Assessment
7.1 Overview
7.2 Technology and Product Offerings
7.3 Product Profile
7.3.1 Covidien (Medtronic)
7.3.2 Sigvaris
7.3.3 BSN Medical
7.3.4 Medi
7.3.5 Laboratoires Innothera
7.3.6 3M Health Care
7.3.7 Thuasne
7.3.8 Paul Hartmann
7.3.9 Mego Afek
7.3.10 Medline Industries
7.3.11 ArjoHuntleigh
7.3.12 DJO Global
7.3.13 Lohmann & Rauscher
7.3.14 Venosan (Salzmann)
7.3.15 Sanyleg
7.3.16 Juzo
7.3.17 Daesung Maref
7.3.18 Bio Compression Systems
7.3.19 Smith & Nephew
7.3.20 Molnlycke Health Care
7.3.21 Gloria Med
7.3.22 B. Braun
7.3.23 Alcare
7.3.24 Derma Sciences
7.3.25 Urgo
7.3.26 Systagenix
7.3.27 Muranaka Medical Instruments
7.3.28 ConvaTec
7.3.29 Xiamen Senyang
7.3.30 Guangzhou Yihao Electronic Technology
7.3.31 Talley Group
7.3.32 Cardinal Health
7.3.33 Tactile Medical
7.3.34 Devon Medical
7.4 SWOT For Each Category of Device
7.4.1 SWOT, Compression Garments
7.4.2 SWOT, Compression Bandages
7.4.3 SWOT, Anti-Embolism Stockings
7.4.4 SWOT, Pneumatic Compression Therapy
8 Pipeline Assessment
8.1 Overview
8.2 Product Profiles
8.2.1 Medical Compression Systems: ActiveCast and ActiveCare Vascular
8.2.2 Epoch Medical Systems: Adaptive Compression for Lower Limb Prosthetics
8.2.3 Footfalls & Heartbeats: Compression Bandage with Textile-based Sensor
9 Clinical Trials to Watch
9.1 Overview
9.2 Clinical Trial Profiles
9.2.1 Evaluation of a Dual Action Pneumatic Compression Device
9.2.2 Treatment Response to Different Lymphedema Compression Programs Using a Pneumatic Compression Device
9.2.3 Two Pneumatic Compression Devices for the Treatment of Lower Extremity Lymphedema
9.2.4 A Hemodynamic Comparison Study of Stationary and Portable Pneumatic Compression Devices
9.2.5 DVT Prevention Study: Geko Neurosmuscular Stimulator vs. Thromboembolism Deterrent Stockings (TEDS)
9.2.6 Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome
9.2.7 Effectiveness of Two Compression Methods in the Treatment of Upper Limb Lymphedema
9.2.8 Clinical Study to Assess Safety and Efficacy of a New Armsleeve in the Management of Arm Lymphedema
10 Current and Future Players
10.1 Overview
10.2 Company Profiles
10.2.1 Covidien (Medtronic)
10.2.2 Sigvaris
10.2.3 BSN Medical
10.2.4 Medi
10.2.5 Innothera
10.2.6 3M Health Care
10.2.7 Thuasne
10.2.8 Paul Hartmann
10.2.9 Mego Afek
10.2.10 Medline Industries
10.2.11 ArjoHuntleigh (Getinge)
10.2.12 DJO Global
10.2.13 Lohmann & Rauscher
10.2.14 Venosan (Salzmann)
10.2.15 Sanyleg (Mimosa)
10.2.16 Juzo
10.2.17 Daesung Maref
10.2.18 Bio Compression Systems
10.2.19 Smith & Nephew
10.2.20 Molnlycke Health Care
10.2.21 Gloria Med
10.2.22 B. Braun
10.2.23 Alcare
10.2.24 Derma Sciences
10.2.25 Laboratoires Urgo
10.2.26 Systagenix (Acelity)
10.2.27 Muranaka Medical Instruments
10.2.28 ConvaTec
10.2.29 Xiamen Senyang
10.2.30 Guangzhou Yihao Electronic Technology
10.2.31 Talley Group
10.2.32 Cardinal Health
10.2.33 Tactile Medical
10.2.34 Devon Medical
10.3 Other Current Players
11 Strategic Competitive Assessment
11.1 Company Market Share
11.1.1 Overview
11.1.2 Company Share in APAC Region
12 Market Outlooks by Market Segment
12.1 APAC
13 Market Outlooks by Geography
13.1 By Region
13.1.1 APAC
13.1.2 Japan
13.1.3 China
13.1.4 India
14 Appendix
14.1 Bibliography
14.2 Abbreviations
14.3 Methodology
14.3.1 Overview
14.3.2 Coverage
14.3.3 Secondary Research
14.4 Forecasting Methodology
14.5 Physicians and Specialists Included in This Study
14.5.1 Key Opinion Leaders
14.5.2 Primary Research Summary
14.6 About the Authors
14.6.1 Shashank Settipalli, Analyst, Medical Devices
14.6.2 Priya Radhakrishnan, MBA, Director, Research and Analysis, Medical Devices
14.7 About GlobalData
14.8 Contact Us
14.9 Disclaimer
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Industry Overview
3.1 Overview
3.2 Anatomy & Physiology
3.2.1 Chronic Venous Disease
3.2.2 Varicose Veins
3.2.3 Venous Leg Ulcers
3.2.4 Venous Thromboembolism and Deep Vein Thrombosis
3.2.5 Lymphedema
3.3 Clinical Outcomes
3.3.1 Venous Conditions
3.3.2 Lymphedema
3.4 Applications of Technology
3.4.1 Static Compression
3.4.2 Pneumatic Compression Devices
3.5 Advantages and Disadvantages of Technology
3.6 Market Access
3.7 Influence of Clinical Trials
3.8 Regulatory Process
3.8.1 Overview
3.8.2 Japan
3.8.3 China
3.8.4 India
3.9 Reimbursement
3.9.1 Overview
3.9.2 Japan
3.9.3 China
3.9.4 India
3.10 Regulatory Issue & Key Deals
3.10.1 Regulatory Issues & Recalls
3.10.2 Mergers, Acquisitions, and Key Partnerships
3.11 Economic Impact
3.11.1 Indirect Costs
3.11.2 Direct Costs
4 Unmet Needs
4.1 Overview
4.2 Improving Patient Education
4.3 Implementing Consistent Bandaging
4.4 Expanding Caregiver Education
4.5 Enhancing Patient Comfort
4.6 Supporting Patient Mobility
5 Market Opportunity Analysis
5.1 Overview
5.2 Engineering Adjustable Garments for Greater Flexibility
5.3 Developing Multilayer Stockings for Easier Application
5.4 Improving Compression Garments by Adding Sensors
5.5 Innovating Automated Bandaging for Consistent Treatment
6 Market Drivers and Barriers
6.1 Drivers
6.1.1 Aging Populations
6.1.2 Cancer-Related Lymphedema
6.1.3 Rising Rates of Obesity
6.1.4 Lymphatic Filariasis in Underdeveloped Regions
6.1.5 The Need for Cost Savings
6.2 Barriers
6.2.1 Insufficient Reimbursement
6.2.2 Patient Compliance
6.2.3 Cost of Care
6.2.4 Medical Device Excise Tax
6.2.5 Availability of Venture Capital
6.3 Substitutes
6.3.1 Procedures to Prevent Thromboembolism
6.3.2 Invasive and Non-invasive Interventions for Varicose Veins
6.3.3 Surgical Interventions for Lymphedema
6.3.4 Pharmacological Options for DVT Management
7 Competitive Assessment
7.1 Overview
7.2 Technology and Product Offerings
7.3 Product Profile
7.3.1 Covidien (Medtronic)
7.3.2 Sigvaris
7.3.3 BSN Medical
7.3.4 Medi
7.3.5 Laboratoires Innothera
7.3.6 3M Health Care
7.3.7 Thuasne
7.3.8 Paul Hartmann
7.3.9 Mego Afek
7.3.10 Medline Industries
7.3.11 ArjoHuntleigh
7.3.12 DJO Global
7.3.13 Lohmann & Rauscher
7.3.14 Venosan (Salzmann)
7.3.15 Sanyleg
7.3.16 Juzo
7.3.17 Daesung Maref
7.3.18 Bio Compression Systems
7.3.19 Smith & Nephew
7.3.20 Molnlycke Health Care
7.3.21 Gloria Med
7.3.22 B. Braun
7.3.23 Alcare
7.3.24 Derma Sciences
7.3.25 Urgo
7.3.26 Systagenix
7.3.27 Muranaka Medical Instruments
7.3.28 ConvaTec
7.3.29 Xiamen Senyang
7.3.30 Guangzhou Yihao Electronic Technology
7.3.31 Talley Group
7.3.32 Cardinal Health
7.3.33 Tactile Medical
7.3.34 Devon Medical
7.4 SWOT For Each Category of Device
7.4.1 SWOT, Compression Garments
7.4.2 SWOT, Compression Bandages
7.4.3 SWOT, Anti-Embolism Stockings
7.4.4 SWOT, Pneumatic Compression Therapy
8 Pipeline Assessment
8.1 Overview
8.2 Product Profiles
8.2.1 Medical Compression Systems: ActiveCast and ActiveCare Vascular
8.2.2 Epoch Medical Systems: Adaptive Compression for Lower Limb Prosthetics
8.2.3 Footfalls & Heartbeats: Compression Bandage with Textile-based Sensor
9 Clinical Trials to Watch
9.1 Overview
9.2 Clinical Trial Profiles
9.2.1 Evaluation of a Dual Action Pneumatic Compression Device
9.2.2 Treatment Response to Different Lymphedema Compression Programs Using a Pneumatic Compression Device
9.2.3 Two Pneumatic Compression Devices for the Treatment of Lower Extremity Lymphedema
9.2.4 A Hemodynamic Comparison Study of Stationary and Portable Pneumatic Compression Devices
9.2.5 DVT Prevention Study: Geko Neurosmuscular Stimulator vs. Thromboembolism Deterrent Stockings (TEDS)
9.2.6 Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome
9.2.7 Effectiveness of Two Compression Methods in the Treatment of Upper Limb Lymphedema
9.2.8 Clinical Study to Assess Safety and Efficacy of a New Armsleeve in the Management of Arm Lymphedema
10 Current and Future Players
10.1 Overview
10.2 Company Profiles
10.2.1 Covidien (Medtronic)
10.2.2 Sigvaris
10.2.3 BSN Medical
10.2.4 Medi
10.2.5 Innothera
10.2.6 3M Health Care
10.2.7 Thuasne
10.2.8 Paul Hartmann
10.2.9 Mego Afek
10.2.10 Medline Industries
10.2.11 ArjoHuntleigh (Getinge)
10.2.12 DJO Global
10.2.13 Lohmann & Rauscher
10.2.14 Venosan (Salzmann)
10.2.15 Sanyleg (Mimosa)
10.2.16 Juzo
10.2.17 Daesung Maref
10.2.18 Bio Compression Systems
10.2.19 Smith & Nephew
10.2.20 Molnlycke Health Care
10.2.21 Gloria Med
10.2.22 B. Braun
10.2.23 Alcare
10.2.24 Derma Sciences
10.2.25 Laboratoires Urgo
10.2.26 Systagenix (Acelity)
10.2.27 Muranaka Medical Instruments
10.2.28 ConvaTec
10.2.29 Xiamen Senyang
10.2.30 Guangzhou Yihao Electronic Technology
10.2.31 Talley Group
10.2.32 Cardinal Health
10.2.33 Tactile Medical
10.2.34 Devon Medical
10.3 Other Current Players
11 Strategic Competitive Assessment
11.1 Company Market Share
11.1.1 Overview
11.1.2 Company Share in APAC Region
12 Market Outlooks by Market Segment
12.1 APAC
13 Market Outlooks by Geography
13.1 By Region
13.1.1 APAC
13.1.2 Japan
13.1.3 China
13.1.4 India
14 Appendix
14.1 Bibliography
14.2 Abbreviations
14.3 Methodology
14.3.1 Overview
14.3.2 Coverage
14.3.3 Secondary Research
14.4 Forecasting Methodology
14.5 Physicians and Specialists Included in This Study
14.5.1 Key Opinion Leaders
14.5.2 Primary Research Summary
14.6 About the Authors
14.6.1 Shashank Settipalli, Analyst, Medical Devices
14.6.2 Priya Radhakrishnan, MBA, Director, Research and Analysis, Medical Devices
14.7 About GlobalData
14.8 Contact Us
14.9 Disclaimer
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.